1 Result(s)

Article

Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c⁺ Expression in Tumor

Mesothelin (MSLN) is overexpressed in several tumors including ovarian cancer and is the target of current trials. There is limited and conflicting data on MSLN prognostic impact in ovarian cancer.

Isabelle Magalhaes, Josefin Fernebro, Sulaf Abd Own, Daria Glaessgen… in Advances in Therapy (2020)